Search - tctmd.com

Displaying 601 - 620 of 1733

Sort: Relevancy | Date

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

News Daily News

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Michael O'Riordan

July 03, 2019

High Levels of Lp(a) Linked to Increased Ischemic Stroke Risk

News Daily News

High Levels of Lp(a) Linked to Increased Ischemic Stroke Risk

Michael O'Riordan

July 01, 2019

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

News Daily News

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

June 18, 2019

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

News Daily News

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

June 13, 2019

Potential Warning Signs Seen for NOAC Use After TAVR

News Daily News

Potential Warning Signs Seen for NOAC Use After TAVR

June 12, 2019

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

Mortality Lower When STEMI Patients Sent to the ICU, but Why?

News Daily News

Mortality Lower When STEMI Patients Sent to the ICU, but Why?

June 06, 2019

Higher Risk of Intracranial Hemorrhage With Aspirin in Primary Prevention

News Daily News

Higher Risk of Intracranial Hemorrhage With Aspirin in Primary Prevention

Michael O'Riordan

May 20, 2019

Taking Ticagrelor? Frank, Proactive Patient Conversations are Needed to Help With Adherence

News Daily News

Taking Ticagrelor? Frank, Proactive Conversations are Needed to Help With Adherence

Yael L. Maxwell

May 17, 2019

Familial Hypercholesterolemia Seen in 10% of Young MI Patients

News Daily News

Familial Hypercholesterolemia Seen in 10% of Young MI Patients

Michael O'Riordan

May 15, 2019

Device-Related Thrombus and LAA Closure: Rare but Dangerous

News Daily News

Device-Related Thrombus and LAA Closure: Rare but Dangerous

Yael L. Maxwell

May 09, 2019

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

News Daily News

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Michael O'Riordan

May 08, 2019

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

News Daily News

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Michael O'Riordan

May 06, 2019

CABANA Results Largely Generalizable to Real-World A-fib Patients

News Daily News

CABANA Results Largely Generalizable to Real-World A-fib Patients

May 03, 2019

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

May 01, 2019

Experts Call on Training Programs to Incorporate Cardio-Oncology to Meet Growing Need

News Daily News

Experts Call on Training Programs to Incorporate Cardio-Oncology to Meet Growing Need

April 30, 2019

No Need for Niacin? Meta-analysis Argues the End Is Nigh

News Daily News

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Yael L. Maxwell

April 22, 2019

EXCEL Insights: CABG Outcomes for Left Main CAD Have Improved Substantially

News Daily News

EXCEL Insights: CABG Outcomes for Left Main CAD Have Improved Substantially

Michael O'Riordan

April 22, 2019

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.